Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Investment in Macrophage Therapeutics, Inc. (Details Textual)

v3.8.0.1
Note 8 - Investment in Macrophage Therapeutics, Inc. (Details Textual) - USD ($)
1 Months Ended 9 Months Ended
Jan. 31, 2017
May 31, 2016
Dec. 31, 2015
Mar. 31, 2015
Sep. 30, 2017
Reclassification of Funds Invested $ 200,000       $ 200,000
MT [Member]          
Convertible Preferred Stock, PIK Coupon, Percentage   10.00%      
Convertible Preferred Stock, Conversion Price, Market Cap   $ 500,000,000      
MT [Member] | Chief Executive Officer [Member]          
Payments to Acquire Businesses and Interest in Affiliates       $ 200,000  
MT [Member] | Platinum [Member]          
Payments to Acquire Businesses and Interest in Affiliates   $ 200,000 $ 200,000 $ 300,000